Skip to content
Disclosery

Crestline Management, L.P.

Follow

13F filer, CIK 1536054, FORT WORTH, TX

Crestline Management, L.P. reported holdings worth $53,476,000 (the sum of its rows) across 3 holdings for the quarter ended 2026-06-30, in a 13F-HR filed 2026-08-14. The total stated on the cover page is $534,760,000.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001315863-26-000592

The cover page states a total of $534,760,000, 900% more than the sum of the rows, $53,476,000. This page uses the sum of the rows.

Period
2026-06-30
Value, sum of rows
$53.5M
Stated on the cover page
$535M
Holdings
3
Top 10 weight
100%
New
0
Sold out
0

Largest buys vs the previous quarter

None.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
DNLIreduced-300,000-$7.72M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2026

Share positions as resolved from 13F-HR 0001315863-26-000592, largest first. % of portfolio is the value over $53,476,000, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
DNLIDENALI THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 4,460,732 shares; 2024Q4: 4,310,732 shares; 2025Q1: 4,160,732 shares; 2025Q2: 3,860,732 shares; 2025Q3: 3,410,732 shares; 2025Q4: 2,810,732 shares; 2026Q1: 2,210,732 shares; 2026Q2: 1,910,732 shares 1,910,732$49.1M91.9%-300,000Timeline
SANASANA BIOTECHNOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 3,085,624 shares; 2024Q4: 2,860,937 shares; 2025Q1: 2,790,937 shares; 2025Q2: 2,420,937 shares; 2025Q3: 1,820,937 shares; 2025Q4: 1,220,937 shares; 2026Q1: 755,736 shares; 2026Q2: 755,736 shares 755,736$2.64M4.93%0Timeline
EGHT8X8 INC NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 998,380 shares; 2024Q4: 998,380 shares; 2025Q1: 990,580 shares; 2025Q2: 990,580 shares; 2025Q3: 990,580 shares; 2025Q4: 990,580 shares; 2026Q1: 990,850 shares; 2026Q2: 990,850 shares 990,850$1.69M3.17%0Timeline

How Q2 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001315863-26-000592 base2026-08-14acceptance time not in the bulk data set